CVE-2018-1000854
esigate.org esigate version 5.2 and earlier contains a CWE-74: Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in ESI directive with user specified XSLT that can result in Remote Code…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (3.16%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
esigate.org esigate version 5.2 and earlier contains a CWE-74: Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in ESI directive with user specified XSLT that can result in Remote Code Execution. This attack appear to be exploitable via Use of another weakness in backend application to reflect ESI directives. This vulnerability appears to have been fixed in 5.3.
- CVSS 3.0
- 9.8 CRITICALCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 3.16% probability · 88th percentile
- Public exploits
- None in Exploit-DB
- CISA KEV
- Not listed
- Weakness
- CWE-74
- Affected
- esigate/esigate
- Source
- cve@mitre.org
EPSS 3.2% since 28 October 2026; no change recorded yet. Points are recorded when the score first appears and whenever it moves by a percentage point or more.
References
- https://github.com/esigate/esigate/issues/209Third Party Advisory
- https://github.com/esigate/esigate/issues/209Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.